Clinical Trial Update: Dose Escalation Study of Kylo-0603 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of Kylo-0603 in healthy subjects has completed, examining initial safety and pharmacokinetics for a potential Nonalcoholic Steat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Kylo-0603

Snippet

Sponsor: Kylonova (Xiamen) Biopharma co., LTD. | Conditions: Nonalcoholic Steatohepatitis | Phase 1 | Status: COMPLETED